尿激酶联合依达拉奉治疗新发脑梗死临床观察被引量：2

下载PDF

导出

摘要目的观察尿激酶联合依达拉奉治疗新发脑梗死的临床疗效。方法选择6 h内新发脑梗死患者,符合溶栓指证者给予尿激酶溶栓治疗,将溶栓后24 h内无脑出血者41例随机分成观察组21例和对照组20例。观察组给予依达拉奉静滴,对照组给予银杏叶提取物静滴。2组患者均给予上述治疗14 d。治疗前及治疗14 d后均进行欧洲卒中量表。结果 ESS评分及Barthel指数(BI)评分,2组进行比较。治疗14 d后,观察组ESS评分为87.37±8.63,对照组为71.28±9.26,2者比较有统计学差异,P<0.05。治疗14 d后的BI评分比较:观察组为79.59±13.56,对照组为65.64±14.43,2者比较有统计学差异,P<0.05。结论对于6 h内急性脑梗死的的患者给予尿激酶溶栓后,联合依达拉奉治疗能明显促进受损神经功能的恢复、提高日常生活的能力。

作者贾舒尹琳

机构地区大连医科大学附属二院神经内科

出处《中国实用神经疾病杂志》 2011年第12期34-35,共2页 Chinese Journal of Practical Nervous Diseases

关键词尿激酶依达拉奉脑梗死

分类号 R743.33 [医药卫生—神经病学与精神病学]

引文网络
相关文献

参考文献6

1Astrup J,Symon L,Siesjo BK,et al. Thresholds in cerebral is- ehemia-the isehemic penumbra[J]. Stroke, 1981,12(6) : 723- 725.
2Ikeda Y, Mochizuki Y, Nakamura Y, et al. Protective effect of a novel vitamin E derivative on experimental traumatic brain ede- ma in rats-preliminary study[J].Acta Neuroehir, 2000,76:343- 345.
3Tottene A, Volsen S ,Pietrobon D. Alpha(1E) subunits form the pore of three cerebellar R type calcium channels with dib ferent pharmacological and permeation properties[J]. J Neurosci,2000,20(1) :171 -178.
4Edaravon Acute Infarction Study Group. Effect of a novel free radical scavenger, edaravone ( MCI-186 ), onacutebraininf- arction. Randomized, placed-controlled, double-blind study at multicenters[J]. Cerebrovnsc Dis, 2003,15 (3) : 222-223.
5黄菊明.依达拉奉对急性脑梗死患者神经元特异性烯醇化酶变化的影响[J].中国实用神经疾病杂志,2008,11(2):73-75. 被引量：8
6刘秀坤,董志.治疗急性脑梗死药依达拉奉应用及其相关机制的研究进展[J].国外医学（药学分册）,2005,32(5):314-317. 被引量：82

二级参考文献21

1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量：33020
2脑卒中患者临床神经功能缺损程度评分标准（1995）[J].中华神经科杂志,1996,29(6):381-383. 被引量：15727
3[3]Corroal J,Rabinowicz AL,Heck CN,et al.Status epilepticus increases CSF levels of neuron-specific enolase and alters the blood-brain barrier[J].Neurology,1998,50(5):1388-1391.
4Oishi R, Itoh Y, Nishibori M, et al. Effect of MCI-186 on ischemiainduced changes in monoamine metabolism in rat brain[J]. Stroke,1989, 20(11): 1557 - 1564.
5Watanabe T, Yuki S, Egawa M, et al. Protective effects of MCI-186on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions[J]. J Pharmacol Exp Ther, 1994, 268(3):1597 - 1604.
6Yamamoto T, Yuki S, Watanabe T, et al. Delayed neuronal death prevented by inhibition of increased hydroxyl radical formation in a transient cerebral ischemia[J]. Brain Res, 1997, 762(1/2):240 -242.
7Watanabe T, Egawa M. Effects of an antistroke agent MCI-186 on cerebral arachidonate cascade[J]. J Pharmacol Exp Ther , 1994,271(3): 1624 - 1629.
8Yoshida H, Sasaki K, Namiki Y, et al. Edaravone, a novel radical scavenger, inhibits oxidative modification of low-density lipoprotein (LDL) and reverses oxidized LDL-mediated reduction in the expression of endothelial nitric oxide synthase [ J ]. Atherosclerosis, 2005,179(1) :97 - 102.
9Amemiya S, Kamiya T, Nito C, et al. Anti-apoptotic and neuroprotective effects of edaravone following transient focal ischemia in rats[J]. Eur J Pharmacol, 2005, 516(2): 125 - 130.
10Takahashi G, Sakurai M, Abe K, et al. MCI-186 prevents spinal cord damage and affects enzyme levels of nitric oxide synthase and Cu/Zn superoxide dismutase after transient ischemia in rabbits[J]. J Thorac Cardiovasc Surg , 2003, 126(5):1464- 1466.